JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265977

Human MAN1C1 (HMIC) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MAN1C1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 28 bp deletion in exon 3.

View Alternative Names

1 2 alpha mannosidase IC, Alpha 1 2 mannosidase IC, HMIC, MAN1A3, MAN1C, MAN1C1, Mannosidase alpha class 1C member 1, Mannosyl oligosaccharide 1 2 alpha mannosidase IC, Processing alpha 1 2 mannosidase IC, pp6318

2 Images
Sanger Sequencing - Human MAN1C1 (HMIC) knockout HeLa cell line (AB265977)
  • Sanger seq

Unknown

Sanger Sequencing - Human MAN1C1 (HMIC) knockout HeLa cell line (AB265977)

Allele-1 : 28 bp deletion in exon 3.

Sanger Sequencing - Human MAN1C1 (HMIC) knockout HeLa cell line (AB265977)
  • Sanger seq

Unknown

Sanger Sequencing - Human MAN1C1 (HMIC) knockout HeLa cell line (AB265977)

Allele-2 : 1 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 28 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265977-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265977 Human MAN1C1 (HMIC) knockout HeLa cell line", "number":"AB265977-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265977-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265977 Human MAN1C1 (HMIC) knockout HeLa cell line", "number":"AB265977-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MAN1C1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HMIC also known as Histone Modifier Inhibitor Complex is a protein complex involved in chromatin modification. It plays an active role in the regulation of gene expression by altering chromatin structure. The complex has a mass of approximately 120 kDa and is found in the nucleus of the cell. Researchers have observed its expression in various tissues including muscle liver and brain indicating its widespread role in cellular processes.
Biological function summary

HMIC influences transcription regulation by participating in the modification of histone tails. It forms part of a larger multi-protein assembly that targets specific lysine residues on histones. This modification alters the chromatin's accessibility to transcription machinery impacting gene expression levels. By modulating histone acetylation and methylation states HMIC links closely with cellular processes like DNA replication and repair.

Pathways

HMIC functions within the chromatin remodeling pathways especially affecting the gene transcription pathway. It involves interactions with proteins such as transcription factors and other chromatin remodelers like Polycomb group proteins. These interactions enable the precise regulation of genes necessary for cell differentiation and development as well as in response to environmental signals.

Abnormal activity of HMIC associates with oncogenesis and neurodegenerative diseases. Its dysregulation can lead to improper gene expression patterns that contribute to cancerous growths or neurodegenerative conditions like Alzheimer's disease. The complex interacts with proteins such as p53 linking its misregulation to tumor development and progression. Similarly altered HMIC activity influences proteins responsible for neuronal survival and function highlighting its relevance in neurobiology.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com